Contemporary influenza diagnostics: Renewed focus on testing patients

Annals of Internal Medicine

Volumn 167, Issue 6, 2017, Pages 438-439

  Ison, Michael G ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT;

AMBULATORY CARE; ANTIVIRAL THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; HUMAN; INFLUENZA; PATIENT ASSESSMENT; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CLINICAL PRACTICE; IMMUNOASSAY; INAPPROPRIATE PRESCRIBING; MOLECULAR DIAGNOSIS; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PROCEDURES; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; HUMANS; IMMUNOASSAY; INAPPROPRIATE PRESCRIBING; INFLUENZA, HUMAN; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION; PRACTICE PATTERNS, PHYSICIANS'; SENSITIVITY AND SPECIFICITY;

EID: 85029718682     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M17-2235     Document Type: Editorial

References (10)

1. Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015; 385:1729-37. [PMID: 25640810] doi:10.1016/S0140-6736(14)62449-1
2. Hurt AC, Kelly H. Debate regarding oseltamivir use for seasonal and pandemic influenza. Emerg Infect Dis. 2016; 22:949-55. [PMID: 27191818] doi:10.3201/eid2206.151037
3. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis. 2013; 207:553-63. [PMID: 23204175] doi: 10.1093/infdis/jis726
4. Venkatesan S, Myles PR, Leonardi-Bee J, Muthuri SG, Al Masri M, Andrews N, et al. Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an individual participant data metaanalysis. Clin Infect Dis. 2017; 64:1328-1334. [PMID: 28199524] doi:10.1093/cid/cix127
5. Ison MG Editorial commentary: failing our patients by subopti-mally treating influenza infections [Editorial]. Clin Infect Dis. 2014; 59: 783-6. [PMID: 25034418] doi:10.1093/cid/ciu425
6. Lee N, Ison MG. Editorial commentary. "Late" treatment with neur-aminidase inhibitors for severely ill patients with influenza: better late than never? [Editorial]. Clin Infect Dis. 2012; 55:1205-8. [PMID: 22843780] doi:10.1093/cid/cis642
7. Havers F, Thaker S, Clippard JR, Jackson M, McLean HQ, Gaglani M, et al. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clin Infect Dis. 2014; 59:774-82. [PMID: 25034419] doi:10.1093/cid/ciu422
8. Appiah GD, Chaves SS, Kirley PD, Miller L, Meek J, Anderson E, et al. Increased antiviral treatment among hospitalized children and adults with laboratory-confirmed influenza, 2010-2015. Clin Infect Dis. 2017; 64:364-367. [PMID: 28013261] doi:10.1093/cid/ciw745
9. Dugas A, Rothman R. Clinical utility of rapid molecular-based influenza testing. Open Forum Infect Dis. 2015; 2:102. [PMID: 27437407] doi:10.1093/ofid/ofv131.22
10. Merckx J, Wali R, Schiller I, Caya C, Gore GC, Chartrand C, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction. A systematic review and meta-analysis. Ann Intern Med. 2017; 167:394-409. doi:10.7326/M17-0848